Abingdon Health Plc

AIM:ABDX Stock Report

Market Cap: UK£29.9m

Abingdon Health Future Growth

Future criteria checks 5/6

Abingdon Health is forecast to grow earnings and revenue by 89.2% and 30.7% per annum respectively while EPS is expected to grow by 88.9% per annum.

Key information

89.2%

Earnings growth rate

88.9%

EPS growth rate

Medical Equipment earnings growth22.6%
Revenue growth rate30.7%
Future return on equityn/a
Analyst coverage

Low

Last updated08 Oct 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

AIM:ABDX - Analysts future estimates and past financials data (GBP Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/2027162N/A21
6/30/2026130N/A01
6/30/20259-2N/A01
6/30/20246-1-2-2N/A
3/31/20246-2-2-2N/A
12/31/20235-2-2-2N/A
9/30/20235-3-1-1N/A
6/30/20234-311N/A
3/31/20233-1100N/A
12/31/20222-18-2-1N/A
9/30/20223-20-5-4N/A
6/30/20223-21-8-8N/A
3/31/20224-17-13-10N/A
12/31/20216-12-17-12N/A
9/30/20219-10-19-13N/A
6/30/202112-7-20-13N/A
3/31/202111-5-14-8N/A
12/31/202011-3-7-3N/A
9/30/20208-3-30N/A
6/30/20205-302N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: ABDX is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.1%).

Earnings vs Market: ABDX is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: ABDX is expected to become profitable in the next 3 years.

Revenue vs Market: ABDX's revenue (30.7% per year) is forecast to grow faster than the UK market (3.5% per year).

High Growth Revenue: ABDX's revenue (30.7% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if ABDX's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y